Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 24, 2008 10:45:52 PM CDT



Breast Cancer Decline Tied to Hormone Drop

Posted Apr 19, 07 9:05 AM CDT in World US Science & Health 

(Newser) – Researchers are linking a dramatic drop in the number of breast cancer cases to the decline in estrogen consumption by menopausal women. Women dropped hormone replacement therapy en mass after a 2002 study tied it to breast cancer risk. Other scientists argued that the decline—about 16,000 fewer new cases per year—may have other causes.

 "This is colossal," said Rowan Chlebowski of Harbor-UCLA Medical Center. "It translates into thousands of fewer breast cancers." The theory is that the hormones may essentially throw gas on the fire of estrogen-related tumors. Without the treatment, they may never grow. A similar study in the U.K. recently linked hormone therapy to ovarian cancer.

Source Washington Post

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
New government numbers give some of the strongest evidence yet that menopause hormones can raise the risk of breast cancer.   (Associated Press)
This image made available by the Duke University Department of Medicine shows a right breast MRI from a 55 year old woman with extreme breast density. The arrow points to a 2.0 cm rapidly enhancing lesion...   (Associated Press)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Related articles

Original sources

Threads (1 of 2)



Loading...

Loading...

Today's Most Popular


Other Home Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »